VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
Development of a Question Prompt Sheet for Cancer Patients Receiving Outpatient Palliative Care.
The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. Ann Surg. 2005 Mar; 241(3):491-6.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Antigens, CD
Antigens, Neoplasm
Biomarkers, Tumor
Carcinoma in Situ
Cell Adhesion Molecules
Female
GPI-Linked Proteins
Humans
Immunohistochemistry
Male
Middle Aged
Pancreatic Neoplasms
Prognosis
Survival Analysis
Survival Rate
authors with profiles
ANIRBAN MAITRA